Protocol for HIV-1 latency reversal using engineered bacteriophage T4 particles

Himanshu Batra1, Venigalla B Rao1

  • 1Bacteriophage Medical Research Center, Department of Biology, The Catholic University of America, Washington, DC, USA.

STAR Protocols
|July 18, 2026
PubMed
Summary

Researchers developed novel CD4-DARPin-T4 nanoparticles to target and reverse latent HIV-1 infection in CD4+ T cells. This approach shows promise for reactivating the virus from its hidden reservoir.